ETFs With AstraZeneca PLC (AZN) Exposure
The following ETFs maintain significant exposure to AstraZeneca PLC (AZN); each of the following funds counts AZN among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|DXPS||WisdomTree United Kingdom Hedged Equity Fund||Europe Equities||0.48%||4.90%|
|PPH||Market Vectors Pharmaceutical ETF||Health & Biotech Equities||0.35%||4.74%|
|AXHE||iShares MSCI ACWI ex U.S. Healthcare ETF||Health & Biotech Equities||0.48%||4.61%|
|FDD||STOXX European Select Dividend Index Fund||Europe Equities||0.60%||4.54%|
|IRY||SPDR S&P International Health Care Sector ETF||Health & Biotech Equities||0.50%||4.47%|
|PID||Intl Dividend Achievers||Foreign Large Cap Equities||0.50%||3.23%|
|DWX||SPDR S&P International Dividend ETF||Foreign Large Cap Equities||0.45%||3.10%|
|EWU||iShares MSCI United Kingdom ETF||Europe Equities||0.52%||2.42%|
|IQDY||FlexShares International Quality Dividend Dynamic Index Fund||Global Equities||0.47%||1.92%|
|IQDE||FlexShares International Quality Dividend Defensive Index Fund||Global Equities||0.47%||1.86%|
|IQDF||FlexShares International Quality Dividend Index Fund||Global Equities||0.47%||1.85%|
|WDIV||SPDR S&P Global Dividend ETF||Global Equities||0.40%||1.72%|
|EFAV||iShares MSCI EAFE Minimum Volatility ETF||Foreign Large Cap Equities||0.20%||1.45%|
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.